SCHEMBL29634819

SCHEMBL29634819

COc1ccc(F)c(O)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 4/20 0.53
RAB9A P51151 3/20 0.53
ALDH1A1 P00352 2/20 0.52
CYP3A4 P08684 2/20 0.52
MAPK1 P28482 2/20 0.52
TRIM24 O15164 1/20 0.52
TYR P14679 1/20 0.52
TRIM33 Q9UPN9 1/20 0.52
HPGD P15428 1/20 0.52
SMN1; SMN2 Q16637 2/20 0.50
MAPT P10636 2/20 0.50
KMT2A Q03164 2/20 0.50
CA3 P07451 1/20 0.50
CA6 P23280 1/20 0.50
CA5A P35218 1/20 0.50
CA9 Q16790 1/20 0.50
CA14 Q9ULX7 1/20 0.50
CA5B Q9Y2D0 1/20 0.50
KDM4E B2RXH2 1/20 0.50
MEN1 O00255 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1620598 1.00 NPC1 (0.53) NPC1RAB9AALDH1A1CYP3A4MAPK1
SCHEMBL459327 0.82 GAA (0.55) NPC1RAB9AALDH1A1CYP3A4MAPK1
SCHEMBL16318931 0.79 NPC1 (0.45) NPC1RAB9AALDH1A1TYRMAPT
SCHEMBL29950410 0.78 ALDH1A1 (0.61) NPC1RAB9AALDH1A1CYP3A4MAPK1
SCHEMBL67498 0.78 ALDH1A1 (0.61) NPC1RAB9AALDH1A1CYP3A4MAPK1
SCHEMBL340086 0.78 NPC1 (0.60) NPC1RAB9AALDH1A1CYP3A4MAPK1
SCHEMBL29513208 0.78 CA12 (0.50) ALDH1A1MAPTKMT2ACA9CA14
SCHEMBL254529 0.78 CA12 (0.50) ALDH1A1MAPTKMT2ACA9CA14
SCHEMBL2701547 0.77 LTA4H (0.52) NPC1RAB9AALDH1A1MAPK1SMN1; SMN2
SCHEMBL51705 0.76 POLB (0.61) NPC1RAB9AALDH1A1CYP3A4MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4240489-A1 KRAS G12D INHIBITORS Mirati Therapeutics, Inc. (US) 2023-09-13 EP disclosed
WO-2022098625-A1 KRAS G12D INHIBITORS Mirati Therapeutics, Inc. (US) 2022-05-12 WO disclosed